Radioiodine and thyroid disease: the beginning*,**
References (33)
- et al.
Treatment of Graves' disease with radioiodine
Am J Med
(1948) Historical background of radioiodine in medicine
N Engl J Med
(1955)Early history (1936–1946) of nuclear medicine in thyroid studies at Massachusetts General Hospital
Med Phys
(1975)Letter to S Hertz,
- et al.
Artificial production of a new kind of radio-element
Nature
(1934) Radioactivity induced by neutron bombardment
Nature
(1934)- et al.
Radioactive iodine as an indicator in the study of thyroid physiology
Proc Soc Exp Biol Med
(1938) - Evans R: Personal communication,...
- et al.
Radioactive iodine as an indicator in thyroid physiology. II. Iodine collection by normal and hyperplastic glands in rabbits
Am J Physiol
(1940)
Jean Frederic Joliot
Int J Radiat Oncol Biol Phys
The rates of absorption of the radioactive isotopes of sodium, potassium, chlorine, bromine, and iodine in normal human subjects
Am J Physiol
Induced radioactivity in tellurium
Physical Rev
Radioactive iodine isotopes
Phys Rev
Studies in iodine metabolism by the use of a new radioactive isotope of iodine
Am J Physiol
Cited by (86)
Clinical perspectives on dosimetry in molecular radiotherapy
2023, Physica MedicaEffects of Radioiodine on the Nasolacrimal System
2022, Endocrine Practice2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease
2022, Endocrinology and Metabolism Clinics of North AmericaCitation Excerpt :ATDs should be discontinued if transaminase levels are more than 3 times the upper limit of normal or if the transaminitis worsens.7 RAI has been a safe and effective treatment option for hyperthyroidism for more than 8 decades.22 RAI is well-tolerated and has few associated adverse effects in treatment doses for GD.7
Nuclear medicine therapy of thyroid goiter
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Theranostics in Thyroid Cancer
2021, PET ClinicsPaediatric Molecular Radiotherapy: Challenges and Opportunities
2021, Clinical OncologyCitation Excerpt :Images of appropriate facilities in an age-appropriate environment are shown in Figure 4. The use of radioactive isotopes of iodine for thyroid diseases started over 75 years ago [23]. The dose schedules used for 131I ablation and therapy for differentiated thyroid cancer were developed empirically.
- *
Supported by the Thyroid Research Fund, Division of Nuclear Medicine, New York, NY (Dr Becker); and an unrestricted grant from Daniels Pharmaceuticals, Inc, St. Petersburg, FL (Dr Sawin).
- **
Presented in part as the Presidential Address, American Thyroid Association, held in New Orleans, LA, October 7, 1983 (Dr Becker).